Allogene Therapeutics, Inc. · NASDAQ:ALLO
Allogene Therapeutics, Inc. shareholders
As of Sep 30, 2026, 192 institutions reported holding Allogene Therapeutics, Inc., 87.7% of its shares. Largest: BlackRock, Citadel and Frazier Life Sciences Management, L.P. New holders, exits, insiders and big stakes, each with its filing.
| Holder | Shares | % of Allogene Therapeutics, Inc. | Change | Filed |
|---|---|---|---|---|
| BlackRock | 30.9M | 8.9% | +780K | Nov 13, 2026 |
| Citadel | 24.6M | 7.1% | +14.5M | Nov 16, 2026 |
| Frazier Life Sciences Management, L.P. | 22.4M | 6.5% | no change | Nov 16, 2026 |
| Pfizer Inc | 22M | 6.4% | no change | Nov 12, 2026 |
| Vanguard | 17.9M | 5.2% | −618K | Nov 16, 2026 |
| State Street | 16.3M | 4.7% | −2.7M | Nov 12, 2026 |
| Primecap Management Co | 13.1M | 3.8% | +23,400 | Nov 12, 2026 |
| UBS | 10.7M | 3.1% | +7.67M | Nov 10, 2026 |
| Fidelity | 10.6M | 3.1% | −1.41M | Nov 10, 2026 |
| Sio Capital Management, LLC | 9.1M | 2.6% | −4.22M | Nov 16, 2026 |